Viking Therapeutics
VKTX
Viking Therapeutics (VKTX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | $65.00 from $75.00 | Aug 11, 2026 |
| Canaccord Genuity | Maintained | Buy | $114.00 from $107.00 | Jul 30, 2026 |
| Lake Street | Initiated Coverage | Buy | $89.00 | May 28, 2026 |
| BTIG | Maintained | Buy | $125.00 | May 1, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $100.00 from $105.00 | Apr 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $102.00 | Mar 23, 2026 |
| Canaccord Genuity | Maintained | Buy | $107.00 from $106.00 | Nov 12, 2025 |
| Canaccord Genuity | Initiated Coverage | Buy | $106.00 | Oct 29, 2025 |
| JP Morgan | Maintained | Overweight | $75.00 from $80.00 | Oct 24, 2025 |
| Morgan Stanley | Maintained | Overweight | $102.00 from $98.00 | Oct 23, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $102.00 | Sep 29, 2025 |
| BTIG | Maintained | Buy | $125.00 | Sep 22, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $102.00 | Aug 19, 2025 |
| Citigroup | Maintained | Neutral | $38.00 from $31.00 | Jul 24, 2025 |
| Raymond James | Maintained | Strong Buy | $122.00 from $125.00 | Jul 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $102.00 | Jun 25, 2025 |
| Truist Securities | Maintained | Buy | $75.00 from $95.00 | Apr 28, 2025 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | $104.00 | Apr 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $102.00 | Apr 24, 2025 |
| Morgan Stanley | Maintained | Overweight | $102.00 from $105.00 | Apr 24, 2025 |
Frequently asked questions
What is the latest analyst rating on VKTX?
On Aug 11, 2026, JP Morgan maintained Viking Therapeutics at Overweight with a price target of $65.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
